Related Experiment Video
Updated: Feb 26, 2026

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Insights
Asthma-COPD overlap (ACO) describes patients with airflow obstruction sharing features of both asthma and COPD. Management remains unclear despite worse outcomes for these patients.
Area of Science:
- Pulmonology
- Respiratory Medicine
Background:
- Asthma-COPD overlap (ACO) identifies patients with chronic airflow obstruction exhibiting characteristics of both asthma and chronic obstructive pulmonary disease (COPD).
- Patients with ACO often experience poorer health outcomes compared to those with asthma or COPD alone.
- Current UK guidelines lack specific recommendations for managing ACO, highlighting a clinical management gap.
Purpose of the Study:
- To explore the challenges associated with managing patients who have asthma-COPD overlap.
- To discuss the diagnostic and treatment considerations for this heterogeneous patient group.
Main Methods:
- Review of current literature and guidelines regarding asthma, COPD, and ACO.
- Analysis of consensus-based reports from organizations like GINA and GOLD.
- Discussion of clinical management strategies for patients with overlapping asthma and COPD features.
Main Results:
- The term ACO is preferred over ACOS (asthma-COPD overlap syndrome) to avoid implying a single disease entity.
- ACO represents a heterogeneous group of patients with complex respiratory conditions.
- There is a need for clearer diagnostic criteria and tailored management plans for ACO.
Conclusions:
- Managing asthma-COPD overlap presents significant challenges due to its heterogeneous nature.
- Further research and guideline development are necessary to optimize care for ACO patients.
- Collaboration between asthma and COPD management strategies is crucial for this patient population.
Abstract:
The term asthma-COPD overlap (ACO) has been suggested for people with chronic airflow obstruction that has features characteristic of both asthma and chronic obstructive pulmonary disease (COPD).1 People with clinical features of asthma and COPD tend to have worse outcomes than those with either asthma or COPD alone, yet their clinical management has remained unclear. UK guidelines currently do not specifically address this issue,2,3 but the Global Initiative for Asthma (GINA) and the Global Initiative for Chronic Obstructive Lung Disease (GOLD) have published a consensus-based report on the diagnosis and treatment of people with asthma, COPD and ACO.1 Although 'asthma-COPD overlap syndrome' (ACOS) was briefly used, some thought that it gave the unhelpful impression that it referred to a single disease entity. Here, we consider some of the challenges in managing this heterogeneous group of patients.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

